Originally aired on Tuesday, September 17th, 2019, from 2:00 PM ET to 3:00 PM ET • Hosted by the Pediatric Community of Practice (PCOP)
"Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study."
(Am J Transplant. 2019 Jun 19. doi: 10.1111/ajt.15505.)
In this article:
[After following] 61 pediatric lung transplant recipients for 2+ years or until they met a composite primary endpoint including bronchiolitis obliterans syndrome/obliterative bronchiolitis, retransplant, or death..., findings raise the possibility that the immunologic impact of CARV following pediatric lung transplant is different than that observed in adults.
Stuart Sweet, MD, PhD • Washington University in St. Louis, St. Louis, MO
Lara Danziger-Isakov, MD, MPH • Cincinnati Children's Hospital Medical Center, Cincinnati, OH